Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2026-03-26 @ 3:53 PM
Study NCT ID:
NCT01151761
Status:
TERMINATED
Last Update Posted:
2016-07-29
First Post:
2010-06-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Sponsor:
Stanford University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HEP0032
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None